Viewing nowCombinationExduo Tablet 10/160 mg
Valsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
International Pharmaceuticals Co., Ltd.

MFDS item code 201404025 · Approved 2014.08.28 · Insurance code 643703860
Treatment of essential hypertension
This medication is used for patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with amlodipine or valsartan.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take the medicine at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted. However, if blood pressure is not adequately controlled with monotherapy using either component, switching directly to this medicine may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine in combination may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction/cholestasis. Older adults aged 65 years or older: Use caution when increasing the dose.
Under 18 years of age: Administration of this medicine is not recommended because safety and efficacy have not been established.
This medication can cause serious harm to the fetus when taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergies to the active ingredients or similar drugs, in pregnant or nursing women, patients with severe kidney or liver disease, or those with certain heart conditions. Patients with low sodium or fluid levels in the body may experience hypotension, so their condition should be carefully assessed prior to administration and should be done under medical supervision. Patients with high potassium levels or those taking medications that can increase potassium levels should have their potassium levels monitored frequently. In patients with renal vascular issues or those who have received kidney transplants, caution should be observed due to the risk of worsening renal function. If symptoms of angioedema occur, use should be discontinued immediately, and it should not be readministered. Patients with heart failure or those recovering from a myocardial infarction should closely monitor their cardiac condition while taking this medication, and acute myocardial infarction patients also require careful observation. This medication should be used with caution or in reduced doses in patients with poor liver function. Dizziness or fatigue may occur while taking this medication, so caution is needed when driving or operating machinery. When taken with other antihypertensive agents, potassium supplements, diuretics, or anti-inflammatory drugs, there may be an increased risk of side effects due to interactions, so consult with a physician. This medication is not recommended for patients under the age of 18 as safety and efficacy have not been adequately established. In case of overdose, severe hypotension or heart function deterioration may occur, so if abnormal symptoms arise, immediate medical attention should be sought.
Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, oropharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, back pain, arthritis, muscle spasms, lethargy, pollakiuria, polyuria, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, elevated serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disturbance, peripheral neuropathy, muscle rigidity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, dysuria, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neuroexcitation, sensory loss, Stevens-Johnson syndrome
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to prevent exposure to air or moisture. It is also advisable to keep the medication at room temperature between 1 to 30 degrees Celsius, away from excessively hot or cold locations.
Bright yellow rectangular film-coated tablet
30 tablets (10 tablets/PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
International Pharmaceuticals Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.